BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 21443962)

  • 21. Early impact of rotavirus vaccination in children less than five years of age in Mozambique.
    de Deus N; Chilaúle JJ; Cassocera M; Bambo M; Langa JS; Sitoe E; Chissaque A; Anapakala E; Sambo J; Guimarães EL; Bero DM; João ED; Cossa-Moiane I; Mwenda JM; Weldegebriel GG; Parashar UD; Tate JE
    Vaccine; 2018 Nov; 36(47):7205-7209. PubMed ID: 29128381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.
    Mpabalwani EM; Simwaka CJ; Mwenda JM; Mubanga CP; Monze M; Matapo B; Parashar UD; Tate JE
    Clin Infect Dis; 2016 May; 62 Suppl 2():S183-7. PubMed ID: 27059354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain.
    Giménez Sánchez F; Nogueira EJ; Sánchez Forte M; Ibáñez Alcalde M; Cobo E; Angulo R; Garrido Fernández P
    Hum Vaccin Immunother; 2016 Apr; 12(4):1035-9. PubMed ID: 26810147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine.
    Chang HG; Smith PF; Tserenpuntsag B; Markey K; Parashar U; Morse DL
    Vaccine; 2010 Jan; 28(3):754-8. PubMed ID: 19896451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.
    Patel MM; Tate JE; Selvarangan R; Daskalaki I; Jackson MA; Curns AT; Coffin S; Watson B; Hodinka R; Glass RI; Parashar UD
    Pediatr Infect Dis J; 2007 Oct; 26(10):914-9. PubMed ID: 17901797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium.
    Raes M; Strens D; Vergison A; Verghote M; Standaert B
    Pediatr Infect Dis J; 2011 Jul; 30(7):e120-5. PubMed ID: 21436757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of hospitalizations with diarrhea among children aged 0-5 years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine.
    Ahmed MC; Heukelbach J; Weddih A; Filali-Maltouf A; Sidatt M; Makhalla K; Dahdi S; Cheikh Ahmed AC; El-Mami MV; Tate JE; Parashar UD; Benhafid M
    Vaccine; 2019 Mar; 37(11):1407-1411. PubMed ID: 30765173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.
    Tsolenyanu E; Djadou KE; Fiawoo M; Akolly DAE; Mwenda JM; Leshem E; Tate JE; Aliabadi N; Koudema W; Guedenon KM; Godonou M; Dagnra A; Gbadoe AD; Boko A; Landoh D; Atakouma Y; Parashar UD
    Vaccine; 2018 Nov; 36(47):7185-7191. PubMed ID: 29397224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential cost-effectiveness of a rotavirus immunization program in rural China.
    Wang XY; Riewpaiboon A; von Seidlein L; Chen XB; Kilgore PE; Ma JC; Qi SX; Zhang ZY; Hao ZY; Chen JC; Xu ZY
    Clin Infect Dis; 2009 Oct; 49(8):1202-10. PubMed ID: 19739973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can routinely collected national data on childhood morbidity and mortality from diarrhea be used to monitor health impact of rotavirus vaccination in Africa? Examination of pre-vaccine baseline data from Rwanda.
    Ngabo F; Gatera M; Karema C; Donnen P; Lepage P; Parashar UD; Tate JE; Mwenda JM; Rugambwa C; Binagwaho A
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S89-93. PubMed ID: 24343621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and burden of rotavirus disease in Central Asia.
    Latipov R; Utegenova E; Kuatbayeva A; Kasymbekova K; Abdykarimov S; Juraev R; Ismailov U; Flem E
    Int J Infect Dis; 2011 Jul; 15(7):e464-9. PubMed ID: 21524932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa.
    Groome MJ; Zell ER; Solomon F; Nzenze S; Parashar UD; Izu A; Madhi SA
    Clin Infect Dis; 2016 May; 62 Suppl 2():S188-95. PubMed ID: 27059355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rotavirus vaccines in Belgium: policy and impact.
    Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
    Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.
    Rahajamanana VL; Raboba JL; Rakotozanany A; Razafindraibe NJ; Andriatahirintsoa EJPR; Razafindrakoto AC; Mioramalala SA; Razaiarimanga C; Weldegebriel GG; Burnett E; Mwenda JM; Seheri M; Mphahlele MJ; Robinson AL
    Vaccine; 2018 Nov; 36(47):7198-7204. PubMed ID: 28958809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
    Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
    Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom.
    Marlow R; Muir P; Vipond B; Lyttle M; Trotter C; Finn A
    Euro Surveill; 2015; 20(48):30077. PubMed ID: 26675375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.